(C) Biological medicines in asthma - historical notes

Date Note
22/07/2025 Revised formulary content. Agreed ERFC May 2025.
10/04/2024 Addition of Tezepelumab (SMC2541), ERFC Aug 23.
30/08/2023 East Region Formulary content agreed - ERFC 09/08/2023.